tiprankstipranks
Trending News
More News >
Leonardo DRS (DRS)
NASDAQ:DRS
Advertisement

Leonardo Drs (DRS) AI Stock Analysis

Compare
963 Followers

Top Page

DRS

Leonardo Drs

(NASDAQ:DRS)

Rating:74Outperform
Price Target:
$48.00
▲(11.01%Upside)
Leonardo DRS's strong financial performance and positive earnings call highlight its growth potential, reflected in a high score. However, the valuation concerns due to high P/E ratio and modest dividend yield, along with mixed technical indicators, temper the overall enthusiasm.
Positive Factors
Defense Modernization
DRS is well aligned with the $150bn budget reconciliation bill, particularly its exposure to c-UAS, AI processing, and integrated missile defense.
Financial Performance
DRS's 1Q25 earnings beat marks a strong start to the year.
Shipbuilding Expansion
The administration's emphasis on shoring up the domestic shipbuilding industry should prove a tailwind for the company.
Negative Factors
Market Valuation
At a ~21.5x EV/2026 EBITDA, DRS is currently trading at a ~3-turn premium to peers, presenting a more balanced risk-reward proposition.
Supply Chain Risk
China's ban on germanium export poses a risk to the weapon sights business, although DRS has several years worth of supply on hand.

Leonardo Drs (DRS) vs. SPDR S&P 500 ETF (SPY)

Leonardo Drs Business Overview & Revenue Model

Company DescriptionLeonardo DRS, Inc., together with its subsidiaries, provides defense products and technologies in the land, air, sea, space, cyber and security, and commercial domains for military applications. It operates in two segments, Advanced Sensing and Computing, and Integrated Mission Systems. The company offers advanced sensor technologies, including infrared systems and sensors for threat detection and situational awareness; uncooled infrared systems and brownout solutions; airborne, ground vehicle mounted, and dismounted soldier electronic warfare (EW) systems; and EW software and training systems, and intelligence solutions. It also provides computing systems for ground vehicles, ships, and submarines; network and data distribution applications; sensor systems; and networked computing infrastructure on military platform. In addition, the company offers force protection systems, such as solutions for counter-unmanned aerial systems, short-range air defense systems, and active protection systems; and power control, distribution, conversion, and propulsion systems, as well as hybrid electric drive propulsion systems, energy storage, gas turbine packages, nuclear instrumentation and controls, and thermal management and refrigeration equipment. It serves the U.S. military, aerospace and defense prime contractors, government intelligence agencies, and international military customers. The company was founded in 1969 and is based in Arlington, Virginia.
How the Company Makes MoneyLeonardo DRS generates revenue through the sale of its defense electronics and technology solutions to government and military organizations. The company's key revenue streams include contracts for the development and supply of advanced military equipment, such as infrared systems, electronic warfare technology, and integrated mission systems. DRS also benefits from long-term partnerships and contracts with the U.S. Department of Defense and other allied military forces, which provide a steady flow of income. Additionally, the company may engage in research and development projects funded by government grants, further contributing to its earnings.

Leonardo Drs Earnings Call Summary

Earnings Call Date:Jul 30, 2025
(Q2-2025)
|
% Change Since: -10.29%|
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Positive
The earnings call reflected strong revenue and bookings growth, positive financial performance, and beneficial opportunities from defense legislation, despite challenges related to germanium supply and tariff uncertainties. The company's raised guidance indicates confidence in continued growth.
Q2-2025 Updates
Positive Updates
Strong Revenue and Bookings Growth
Q2 revenue was $829 million, a 10% increase year-over-year. The company secured $853 million in bookings, maintaining a 1.0 book-to-bill ratio, with total backlog rising 9% year-over-year to $8.6 billion.
Positive Financial Performance
Adjusted EBITDA increased by 17%, with a margin expansion of 70 basis points. Adjusted diluted EPS rose by 28%, reflecting strong core operating performance and reduced interest expense.
Revised Full-Year Guidance
Leonardo DRS, Inc. raised its full-year revenue growth expectations to 9% to 11%, with a revised revenue range of $3.525 to $3.6 billion, and adjusted EBITDA range between $437 and $453 million.
Opportunities from Defense Legislation
The One Big Beautiful Bill Act includes $150 billion in defense funding, presenting significant opportunities for Leonardo DRS, Inc., with emphasis on shipbuilding, air and missile defense, and electronic warfare.
International Demand Growth
Global defense spending is rising, with NATO members targeting 5% of GDP for national security, supporting international demand for Leonardo DRS, Inc.'s differentiated capabilities.
Negative Updates
Germanium Supply Challenges
Export restrictions have constrained global supply of germanium, impacting raw material costs and creating absorption issues. Mitigation efforts are underway but relief is expected in 2026.
Tariff and Trade Uncertainty
The expiration of temporary tariff reprieves poses risks, including potential retaliatory trade restrictions on critical minerals, affecting operational planning.
Increased R&D Expenses
Increased internal research and development investments have impacted margins, with R&D expenses rising from 2.8% to mid-3% of revenue.
Company Guidance
During the second quarter of fiscal year 2025, Leonardo DRS, Inc. reported strong financial performance, achieving $853 million in bookings, a 1.0 book-to-bill ratio, and a 9% increase in total backlog to $8.6 billion. The company delivered double-digit organic revenue growth, with revenue reaching $829 million, marking a 10% year-over-year increase. Adjusted EBITDA rose by 17% to $96 million, with margins expanding by 70 basis points to 11.6%. Adjusted diluted EPS increased by 28%, reaching $0.23 per share. The company revised its full-year revenue growth expectations to 9% to 11% and adjusted EBITDA guidance to $437-$453 million, driven by strong demand, particularly in the electric power and propulsion, advanced infrared sensing, and naval network computing segments. Despite challenges such as germanium supply issues, Leonardo DRS remains focused on disciplined execution and is optimistic about future growth, buoyed by favorable defense funding legislation and increasing global defense spending.

Leonardo Drs Financial Statement Overview

Summary
Leonardo DRS demonstrates strong financial performance with impressive revenue growth, improved gross profit margins, and robust profitability as shown by solid EBIT and net profit margins. The balance sheet is stable with low leverage and a strong equity base. Cash flow metrics further bolster its financial position, indicating strong cash generation capabilities.
Income Statement
85
Very Positive
Leonardo DRS has shown strong revenue growth over recent years, with an increase from $2,778 million in 2020 to $3,345 million in TTM (Trailing-Twelve-Months). The gross profit margin has improved to 22.7%, reflecting efficient cost management. The EBIT margin is consistent at 9.3%, and the net profit margin is solid at 7.0%. These metrics indicate robust profitability and operational efficiency, making the income statement a strong point for the company.
Balance Sheet
78
Positive
The company's balance sheet reveals a stable financial position with a debt-to-equity ratio of 0.14, indicating low leverage. The equity ratio stands at 62.8%, highlighting a strong equity base. The return on equity is healthy at 9.1%, showing effective use of shareholder funds. Overall, the balance sheet is solid, though there is room for improvement in liquidity and asset utilization.
Cash Flow
80
Positive
Leonardo DRS demonstrates positive cash flow dynamics with a significant increase in free cash flow to $291 million in TTM. The operating cash flow to net income ratio is 1.70, indicating strong cash generation relative to earnings. The free cash flow growth rate is impressive, highlighting the company's ability to generate surplus cash even after capital expenditures. These factors contribute to a strong cash flow position.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.42B3.23B2.83B2.69B2.88B2.78B
Gross Profit792.00M736.00M648.00M575.00M547.00M494.00M
EBITDA358.00M376.00M313.00M624.00M293.00M229.00M
Net Income250.00M213.00M168.00M405.00M154.00M85.00M
Balance Sheet
Total Assets4.08B4.18B3.92B3.68B3.07B2.96B
Cash, Cash Equivalents and Short-Term Investments278.00M598.00M467.00M306.00M240.00M61.00M
Total Debt353.00M458.00M497.00M394.00M490.00M530.00M
Total Liabilities1.48B1.63B1.60B1.55B1.48B1.53B
Stockholders Equity2.60B2.56B2.33B2.13B1.59B1.43B
Cash Flow
Free Cash Flow235.00M186.00M145.00M-32.00M118.00M69.00M
Operating Cash Flow336.00M271.00M205.00M33.00M178.00M125.00M
Investing Cash Flow-100.00M-84.00M-59.00M436.00M39.00M-70.00M
Financing Cash Flow-107.00M-56.00M15.00M-403.00M-38.00M-80.00M

Leonardo Drs Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price43.24
Price Trends
50DMA
45.04
Negative
100DMA
40.30
Positive
200DMA
36.52
Positive
Market Momentum
MACD
0.51
Positive
RSI
37.98
Neutral
STOCH
51.32
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DRS, the sentiment is Neutral. The current price of 43.24 is below the 20-day moving average (MA) of 47.10, below the 50-day MA of 45.04, and above the 200-day MA of 36.52, indicating a neutral trend. The MACD of 0.51 indicates Positive momentum. The RSI at 37.98 is Neutral, neither overbought nor oversold. The STOCH value of 51.32 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DRS.

Leonardo Drs Risk Analysis

Leonardo Drs disclosed 55 risk factors in its most recent earnings report. Leonardo Drs reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Leonardo Drs Peers Comparison

Overall Rating
UnderperformOutperform
Sector (67)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$13.69B47.6428.24%0.64%9.87%14.16%
74
Outperform
$12.79B55.149.99%0.42%11.43%31.92%
71
Outperform
$9.05B22.8813.36%0.09%22.29%51.90%
71
Outperform
$10.30B18.9212.27%2.07%-1.04%-21.80%
68
Neutral
$9.39B133.74
16.92%
67
Neutral
£2.82B10.484.69%3.54%2.70%-19.89%
60
Neutral
$20.99B-45.38%64.98%-10.52%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DRS
Leonardo Drs
43.24
15.18
54.10%
ERJ
Embraer SA
54.83
23.80
76.70%
HII
Huntington Ingalls
258.52
-14.48
-5.30%
BWXT
BWX Technologies
152.38
53.80
54.57%
RKLB
Rocket Lab USA
46.44
41.20
786.26%
SARO
StandardAero, Inc.
28.18
-4.79
-14.53%

Leonardo Drs Corporate Events

DividendsFinancial Disclosures
Leonardo DRS Reports Strong Q2 2025 Financial Results
Positive
Jul 30, 2025

Leonardo DRS reported strong financial results for the second quarter of 2025, with a 10% increase in revenue to $829 million and a 42% rise in net earnings to $54 million compared to the previous year. The company also announced a $0.09 cash dividend per share to be paid on September 3, 2025, and highlighted its continued focus on disciplined execution amidst a dynamic macroeconomic environment. The results reflect healthy bookings, solid organic revenue growth, and improved profitability driven by increased demand for its advanced technologies.

The most recent analyst rating on (DRS) stock is a Hold with a $29.00 price target. To see the full list of analyst forecasts on Leonardo Drs stock, see the DRS Stock Forecast page.

Shareholder Meetings
Leonardo DRS Stockholders Approve Key Proposals at Meeting
Neutral
Jun 5, 2025

On June 4, 2025, Leonardo DRS held its Annual Meeting where stockholders voted on various proposals. The election of directors saw significant support, with most nominees receiving over 250 million votes in favor. Additionally, the advisory resolution on executive compensation and the ratification of Ernst & Young LLP as the independent auditor were approved. An amendment to the company’s certificate of incorporation to remove certain supermajority voting requirements was also passed.

The most recent analyst rating on (DRS) stock is a Hold with a $30.00 price target. To see the full list of analyst forecasts on Leonardo Drs stock, see the DRS Stock Forecast page.

Financial Disclosures
Leonardo DRS Reports Strong Q1 2025 Financial Results
Positive
May 1, 2025

Leonardo DRS reported strong financial results for the first quarter of 2025, ending March 31, with a 16% increase in revenue to $799 million and a 72% rise in net earnings to $50 million compared to the previous year. The company also achieved a book-to-bill ratio of 1.2x with $1 billion in bookings and an $8.6 billion backlog, reflecting robust demand for its products and services. The improved profitability and reduced cash flow usage indicate a solid start to the year, positioning the company well for future growth and shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025